Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-020457

CONSTELLATION PHARMACEUTICALS INC · CNST

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Eli Casdin
10% Owner
Period of report
Jul 23, 2018
Accepted (ET)
Jul 23, 2018 · 8:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434418

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jul 23, 2018C345,783—A345,783ISee footnote
Common StockF2Jul 23, 2018P266,667$15.00A612,450ISee footnote
Common StockF1,F3Jul 23, 2018C158,960—A158,960ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series E Preferred StockF2,F1—Jul 23, 2018C1,333,333D——Common Stock155,7160I
Series E-1 Preferred StockF2,F1—Jul 23, 2018C342,435D——Common Stock31,1040I
Series F Preferred StockF2,F1—Jul 23, 2018C1,750,000D——Common Stock158,9630I
Series F Preferred StockF3,F1—Jul 23, 2018C1,750,000D——Common Stock158,9600I

Explanation of responses